Zobrazeno 1 - 10
of 192
pro vyhledávání: '"Murray L, Barclay"'
Autor:
Ping Siu Kee, Simran D. S. Maggo, Martin A. Kennedy, Murray L. Barclay, Allison L. Miller, Klaus Lehnert, Maurice A. Curtis, Richard L. M. Faull, Remai Parker, Paul K. L. Chin
Publikováno v:
Frontiers in Genetics, Vol 13 (2022)
Omeprazole is extensively used to manage gastroesophageal reflux disease (GERD). It is primarily metabolized by CYP2C19. The CYP2C19*17 (rs12248560) allele and the recently described CYP2C:TG haplotype (rs11188059 and rs2860840) are associated with i
Externí odkaz:
https://doaj.org/article/1a6d85326f064630b4559320e165eea4
Autor:
Femke Crouwel, Melek Simsek, Amarylle S van Doorn, Chris J J Mulder, Hans J C Buiter, Murray L Barclay, Timothy H Florin, Nanne K de Boer
Publikováno v:
Crouwel, F, Simsek, M, van Doorn, A S, Mulder, C J J, Buiter, H J C, Barclay, M L, Florin, T H & de Boer, N K 2023, ' Rectally Administrated Thioguanine for Distal Ulcerative Colitis : A Multicenter Case Series ', Inflammatory Bowel Diseases, vol. 29, no. 6, pp. 1000-1004 . https://doi.org/10.1093/ibd/izac195
Inflammatory Bowel Diseases, 29(6), 1000-1004. John Wiley and Sons Inc.
Inflammatory Bowel Diseases, 29(6), 1000-1004. John Wiley and Sons Inc.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5a8eb4e383ab0f634d5f5207391918cd
https://doi.org/10.1093/ibd/izac195
https://doi.org/10.1093/ibd/izac195
Autor:
Lisa K. Stamp, Peter T. Chapman, Murray L. Barclay, Anne Horne, Christopher Frampton, Paul Tan, Jill Drake, Nicola Dalbeth
Publikováno v:
Arthritis Research & Therapy, Vol 20, Iss 1, Pp 1-7 (2018)
Abstract Objective Allopurinol dosing has frequently been limited based on creatinine clearance (CrCL), resulting in failure to achieve target serum urate (SU). The aim of this analysis was to determine how many milligrams of allopurinol above the re
Externí odkaz:
https://doaj.org/article/3b197cbf88d745de807f51367c029381
Autor:
Jan, Kubovy, Murray L, Barclay
Publikováno v:
The New Zealand medical journal. 135(1562)
To ascertain Helicobacter pylori (Hp) diagnosis trends and cost in a New Zealand cohort.All Hp tests within Canterbury between 2013-2018 were retrospectively reviewed, exclusive of histology. Overall numbers for each test modality, expenditure and te
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::95d733894608f3ced78f02d257bb100e
https://pubmed.ncbi.nlm.nih.gov/36137766
https://pubmed.ncbi.nlm.nih.gov/36137766
Autor:
Murray L. Barclay, Gary Lim, Thomas Mules, Steven Ding, Jeffrey Ngu, Teresa Chalmers-Watson, Richard B. Gearry, Michael J. Burt, Tyara Banerjee, James D. Falvey, Catherine A.M. Stedman, Bruce A. Chapman
Publikováno v:
GastroHep. 3:5-11
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5629d026b24c17b91aaa572c381abf3b
https://doi.org/10.1002/ygh2.436
https://doi.org/10.1002/ygh2.436
Publikováno v:
Internal medicine journal.
New Zealand went into 'lockdown' March 2020 successfully eliminating circulating COVID19 virus. During 'lockdown' there were reduced rates of respiratory infections and hospital admissions numbers were low. At the time rumors of benefit and harm of m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::97d4670f501bae092e085fa5f3688b52
https://pubmed.ncbi.nlm.nih.gov/36510392
https://pubmed.ncbi.nlm.nih.gov/36510392
Autor:
Olivia Robyn Clendon, Paul K. L. Chin, Matthew P. Doogue, Amanda May Crawford, Judith M. Dalrymple, Murray L. Barclay, QianYi Chuah, Philip G. Drennan
Publikováno v:
Internal Medicine Journal. 50:1225-1231
BACKGROUND An electronic prescribing and administration (ePA) system has been progressively rolled out to Canterbury District Health Board (CDHB, Christchurch, New Zealand) public hospitals since 2014, and is currently used for around 1300 tertiary b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cbce102bd89592d4c7811b631e337b3b
https://doi.org/10.1111/imj.14706
https://doi.org/10.1111/imj.14706
Publikováno v:
Alimentary Pharmacology & Therapeutics
van Doorn, A S, Meijer, B, Frampton, C M A, Barclay, M L & de Boer, N K H 2020, ' Systematic review with meta-analysis : SARS-CoV-2 stool testing and the potential for faecal-oral transmission ', Alimentary Pharmacology and Therapeutics, vol. 52, no. 8, pp. 1276-1288 . https://doi.org/10.1111/apt.16036
van Doorn, A S, Meijer, B, Frampton, C M A, Barclay, M L & de Boer, N K H 2020, ' Systematic review with meta-analysis : SARS-CoV-2 stool testing and the potential for faecal-oral transmission ', Alimentary Pharmacology and Therapeutics, vol. 52, no. 8, pp. 1276-1288 . https://doi.org/10.1111/apt.16036
Background: Since the start of the COVID-19 pandemic, there have been many scientific reports regarding gastrointestinal manifestations. Several reports indicate the possibility of viral shedding via faeces and the possibility of faecal-oral transmis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::63afe075e16924440a15f83cdaca5f08
http://www.scopus.com/inward/record.url?scp=85089867703&partnerID=8YFLogxK
http://www.scopus.com/inward/record.url?scp=85089867703&partnerID=8YFLogxK
Autor:
Murray L. Barclay, Chris Frampton, Peter T. Chapman, Jill Drake, Lisa K. Stamp, Mei Zhang, John L OʼDonnell
Publikováno v:
JCR: Journal of Clinical Rheumatology. 25:284-287
The aim of this study was to determine whether reducing the dose of supplemental folic acid used in conjunction with methotrexate (MTX) therapy in people with active rheumatoid arthritis (RA) improved disease control and/or increased MTX-related adve
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::51b9765a348a07c6c436cc2844567c7a
https://doi.org/10.1097/rhu.0000000000000848
https://doi.org/10.1097/rhu.0000000000000848
Autor:
Barry D. Hock, Shwan Karim, Michael Schultz, Lisa K. Stamp, Esther T. Johanna Helms, Paula E. Keating, Murray L. Barclay
Publikováno v:
Internal Medicine Journal. 49:513-518
BACKGROUND Therapeutic drug monitoring of anti-tumour necrosis factor (TNF) drugs and anti-drug antibodies (ADA) is now recommended in the treatment of inflammatory bowel disease. However, assay types and drug concentration thresholds are still debat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6a8036b97dbfba9ae39c51f104d54e3a
https://doi.org/10.1111/imj.14064
https://doi.org/10.1111/imj.14064